FDA Warning Letter Flags Empower Pharmacy Compounded GLP-1 Telehealth Menus
FDA's September 18, 2026 warning letter to Empower Pharmacy ties high-volume compounded GLP-1 combinations to telehealth-style menus that preselect significant-difference language under section 503A.